Tango Therapeutics, Inc
201 Brookline Ave Ste 901
Boston, MA 02215
Tango Therapeutics, Inc., based in Boston, MA, is pioneering the development of medicines that leverage the principle of synthetic lethality to target specific tumors. The company focuses on expanding the reach of genetically targeted therapies through a patient-centered approach.
With a robust pipeline of programs, Tango Therapeutics is actively engaged in clinical trials, including those for their innovative compounds TNG462 and TNG456. Their leadership is dedicated to creating impactful therapies that meet the needs of patients with challenging cancers.
Generated from the website
Also at this address
See a problem?
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.